Levels of inflammatory cytokines have been found to be altered in gld.apoE−/− mice (mice with lupus-like features and atherosclerosis, which have absent functional Fas ligand and apolipoprotein E) treated with statins [70]. This evidence concerns the gene FASLG and systemic lupus erythematosus.